Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Cholangiocarcinoma × Clinical Protocols × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Leukemia, Myeloid, Acute 4 Recurrence 2 Squamous Cell Carcinoma of Head and Neck 1 Pancreatic Neoplasms 1 Neoadjuvant Therapy in Rectal Cancer, Radiotherapy, FOLFOX 1 Myelodysplastic Syndromes 1 Lymphoma, Mantle-Cell 1 Lymphoma, Extranodal NK-T-Cell 1 Lymphoma, B-Cell 1 Locally Advanced Breast Cancer 1 Cholangiocarcinoma 1 Breast Neoplasms 1

Interventions

Gemcitabine 52 Cisplatin 29 Oxaliplatin 24 Fluorouracil 19 lenvatinib 18 durvalumab 18 Capecitabine 16 Leucovorin 13 pembrolizumab 9 apatinib 9 tislelizumab 7 sintilimab 6 pemigatinib 6 Radiotherapy 6 Panitumumab 6 Floxuridine 6 Albumin-Bound Paclitaxel 6 tremelimumab 5 olaparib 5 Taxes 5 Specimen Handling 5 Magnetic Resonance Spectroscopy 5 Folfox protocol 5 Drug Therapy 5 Bevacizumab 5 camrelizumab 4 Nivolumab 4 Irinotecan 4 Carboplatin 4 Biopsy 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05557578 2025-02-11

GOT

Zhejiang Cancer Hospital

Phase 2 Recruiting

Gastrointestinal

Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡